33
/es/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
August 1, 2025
Public Timelines
Menu
Public Timelines
FAQ
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
Crear
Close
Create a timeline
Public timelines
Library
FAQ
editar
Descargar
Export
Crear una copia
Premium
Insertar en el Sitio Web
Share
asdfg
Category:
Otro
Actualizado:
16 oct 2017
0
0
374
Autores
Created by
Daniel Rossi
Attachments
Comments
Eventos
Founded as Genetix Pharmaceuticals
Jesse Gelsinger Dies, Interest Lost in Gene Therapy
Series A Financing, $20 million raised
Phase I/II Beta Thallassemia trial launched
Genetix Launches ADL Program
Series B, $35 million raised, new CEO from Third Rock Ventures
Series C, $35 million
Series D, $60 million
Initial Public Offering, $116 million
Cash assets expected to run out
Phase 3 End Date, Beta Thalassemia
Phase 2/3 end date, ALD
About & Feedback
Acuerdo
Privacidad
Biblioteca
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments